Rosiglitazone hydrochloride

Synonyms: 盐酸罗格列酮; BRL 49653 hydrochloride
Rosiglitazone (BRL 49653) hydrochloride 是一种具有口服活性的 PPARγ 选择性激动剂(EC50: 60 nM,Kd: 40 nM),同时也是 TRPC5 激活剂(EC50: 30 μM)和 TRPM3 抑制剂,可用于肥胖、糖尿病、衰老及卵巢癌的研究。
产品编号: MS-H71359 纯度: 99.81% CAS No.: 302543-62-0 分子式: C18H20ClN3O3S 分子量: 393.89
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
3-5 天
500mg
询价
询价
1g
询价
询价

产品描述

Rosiglitazone (BRL 49653) hydrochloride 是一种具有口服活性的 PPARγ 选择性激动剂(EC50: 60 nM,Kd: 40 nM),同时也是 TRPC5 激活剂(EC50: 30 μM)和 TRPM3 抑制剂,可用于肥胖、糖尿病、衰老及卵巢癌的研究。

生物实验数据

生物活性 Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM) that also acts as a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor, and can be used for research on obesity, diabetes, aging, and ovarian cancer.
IC50 & Target PPARγ2:100 nM (EC50), PPARγ1:30 nM (EC50), PPARγ:40 nM (Kd)
体外研究
(In Vitro)

Rosiglitazone hydrochloride (0.1-10 μM, 72 h) results in pluripotent C3H10T1/2 stem cell differentiation to adipocytes.
Rosiglitazone hydrochloride (1 μM, 24 h) activates PPARγ, which binds to NF-α1 promoter to activate gene transcription in neurons.
Rosiglitazone hydrochloride (1 μM, 24 h) protects Neuro2A cells and hippocampal neurons against oxidative stress, and up-regulates BCL-2 expression in an NF-α1-dependent manner.
Rosiglitazone hydrochloride (0.01-100 μM, 15 min) inhibits TRPM3 with IC50 values of 9.5 and 4.6 μM against nifedipine- and PregS-evoked activity respectively.
Rosiglitazone hydrochloride (0.5-50 μM, 7 days) inhibits ovarian cancer cell proliferation.
Rosiglitazone hydrochloride (5 μM, 7 days) suppresses Olaparib (MS-Y92542) induced alterations of cellular senescence and promotes apoptosis in A2780 and SKOV3 cells.

Cell Proliferation Assay

Cell Line: A2780 and SKOV3 cells
Concentration: 0.5-50 μM
Incubation Time: 1-7 days
Result: Inhibited cell proliferation in a time‑dependent and concentration‑dependent manner.

Western Blot Analysis

Cell Line: Hippocampal neurons
Concentration: 1 μM
Incubation Time: 1 μM
Result: Increased NF-α1 and BCL-2 protein level.
体内研究
(In Vivo)

Rosiglitazone hydrochloride (oral administration, 5 mg/kg, daily for 8 weeks) decreases the serum glucose in diabetic rats.
Rosiglitazone hydrochloride (intraperitoneal injection, 3 mg/kg/day) ameliorates airway inflammation induced by cigarette smoke via inhibiting the M1 macrophage polarization by activating PPARγ and RXRα in male Wistar rats.
Rosiglitazone hydrochloride (intraperitoneal injection, 10 mg/kg, once every 2 days) inhibits subcutaneous ovarian cancer growth in A2780 and SKOV3 mouse subcutaneous xenograft models.

Animal Model: Streptozotocin (STZ)-induced diabetic rats
Dosage: 5 mg/kg
Administration: Oral administration, daily for 8 weeks.
Result: Decreased IL-6, TNF-α, and VCAM-1 levels in diabetic group.
Displayed lower levels of lipid peroxidation and NOx with an increase in aortic GSH and SOD levels compared to diabetic groups.
Animal Model: Male Wistar rats
Dosage: 3 mg/kg/day
Administration: Intraperitoneal injection, twice a day, 6 days per week for 12 consecutive weeks
Result: Ameliorated emphysema, elevated PEF, and higher level of total cells, neutrophils and cytokines (TNF-α and IL-1β) induced by cigarette smoke (CS).
Inhibited CS-induced M1 macrophage polarization and decreased the ratio of M1/M2.
性状 固体
颜色 White to off-white

化学信息

分子量 393.89
分子式 C18H20ClN3O3S
CAS No. 302543-62-0
别名 盐酸罗格列酮; BRL 49653 hydrochloride

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (25.39 mM), Sonication is recommended.
10% DMSO+90% Saline: 10 mg/mL (25.39 mM), Solution.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式

-20°C, sealed storage, away from moisture

*In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 62.5 mg/mL (158.67 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.5388 mL12.6939 mL25.3878 mL63.4695 mL
5 mM0.5078 mL2.5388 mL5.0776 mL12.6939 mL
10 mM0.2539 mL1.2694 mL2.5388 mL6.3469 mL
15 mM0.1693 mL0.8463 mL1.6925 mL4.2313 mL
20 mM0.1269 mL0.6347 mL1.2694 mL3.1735 mL
25 mM0.1016 mL0.5078 mL1.0155 mL2.5388 mL
30 mM0.0846 mL0.4231 mL0.8463 mL2.1156 mL
40 mM0.0635 mL0.3173 mL0.6347 mL1.5867 mL
50 mM0.0508 mL0.2539 mL0.5078 mL1.2694 mL
60 mM0.0423 mL0.2116 mL0.4231 mL1.0578 mL
80 mM0.0317 mL0.1587 mL0.3173 mL0.7934 mL
100 mM0.0254 mL0.1269 mL0.2539 mL0.6347 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础